Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
39.77
+0.09 (0.23%)
At close: Mar 9, 2026, 4:00 PM EDT
39.77
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $2.05 billion as of March 9, 2026. Its market cap has increased by 0.42% in one year.
Market Cap
2.05B
Enterprise Value
1.62B
1-Year Change
0.42%
Ranking
Category
Stock Price
$39.77
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $2.05B, an increase of 8,212.15%. That is a compound annual growth rate of 47.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.05B | -17.63% |
| Dec 31, 2025 | 2.49B | 28.31% |
| Dec 31, 2024 | 1.94B | 57.88% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 2.16B |
| Galapagos NV | 2.15B |
| Ascentage Pharma Group International | 2.13B |
| Iovance Biotherapeutics | 2.11B |
| Mineralys Therapeutics | 2.10B |
| Mesoblast | 2.08B |
| Ultragenyx Pharmaceutical | 2.05B |
| Stoke Therapeutics | 2.03B |